We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

120 hedge funds and large institutions have $58.1M invested in Sanofi Contingent Value Rights in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 12 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more capital invested

Capital invested by funds: $39.6M → $58.1M (+$18.5M)

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

3% more funds holding

Funds holding: 116 → 120 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

57% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 28

Holders
120
Holders Change
+4
Holders Change %
+3.45%
% of All Funds
3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
12
Reduced
28
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$3.5M
2
PC
PointState Capital
New York
+$2.47M
3
FCM
Farallon Capital Management
California
+$1.35M
4
TAM
TFG Asset Management
Cayman Islands
+$904K
5
HCM
Highbridge Capital Management
New York
+$750K

Top Sellers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$1.97M
2
WA
Whitebox Advisors
Minnesota
-$1.68M
3
NGA
New Generation Advisors
Massachusetts
-$1.55M
4
BHMP
Bardin Hill Management Partners
New York
-$994K
5
Millennium Management
Millennium Management
New York
-$254K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
51
Virtu KCG Holdings
New York
$7K +$6.5K +19,188 New
ISL
52
Ingalls & Snyder LLC
New York
$6K -$14 -40 -0.3%
BIA
53
Biondo Investment Advisors
Pennsylvania
$6K – – –
CS
54
Credit Suisse
Switzerland
$6K – – –
HK
55
Horizon Kinetics
New York
$6K – – –
MC
56
Moors & Cabot
Massachusetts
$6K – – –
RL
57
Ruffer LLP
United Kingdom
$5K – – –
TSS
58
Two Sigma Securities
New York
$4K -$571 -1,688 -14%
PNC Financial Services Group
59
PNC Financial Services Group
Pennsylvania
$4K -$95 -280 -3%
RJA
60
Raymond James & Associates
Florida
$4K -$87 -256 -2%
BlackRock
61
BlackRock
New York
$4K – – –
DA
62
Dillon & Associates
Michigan
$4K – – –
Wolverine Trading
63
Wolverine Trading
Illinois
$4K – – –
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
$3K – – –
Deutsche Bank
65
Deutsche Bank
Germany
$3K – – –
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$2.07K – – –
AG
67
Advisor Group
Arizona
$2K +$1.18K +3,474 +241%
CTC
68
Central Trust Company
Missouri
$1K -$569 -1,680 -36%
Creative Planning
69
Creative Planning
Kansas
$1K -$184 -544 -13%
US Bancorp
70
US Bancorp
Minnesota
$1K -$125 -370 -17%
WTC
71
WhitTier Trust Company
Nevada
$1K -$29 -85 -5%
RWA
72
Ropes Wealth Advisors
Massachusetts
$1K – – –
EWM
73
Edge Wealth Management
New York
$1K +$12 +34 New
Royal Bank of Canada
74
Royal Bank of Canada
Ontario, Canada
$1K +$105 +309 +11%
WEC
75
Winslow Evans & Crocker
Massachusetts
$524 – – –
1 2
3
4 5

GCVRZ Hedge Fund Activity: Q4 2016 in Review

120 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2016, worth a combined $58.1M — up 47% from $39.6M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new GCVRZ positions and 13 closed out — a net gain of 4 holders — while 12 added to existing stakes and 28 trimmed.

The largest buyer was Stonehill Capital Management, adding an estimated $3.5M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $1.97M.

  • 120 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2016, up from 116 in Q3 2016.
  • Funds reported $58.1M of Sanofi Contingent Value Rights stock for Q4 2016, up 47% quarter-over-quarter.
  • 17 funds opened new Sanofi Contingent Value Rights positions in Q4 2016 and 13 closed out, a net change of +4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2016 was Stonehill Capital Management, an estimated $3.5M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2016 was TPG Group Holdings (SBS) Advisors, an estimated $1.97M sold.

Based on aggregated 13F filings for Q4 2016.